BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mosca A, Panera N, Crudele A, Alisi A. Noninvasive diagnostic tools for pediatric NAFLD: where are we now? Expert Review of Gastroenterology & Hepatology 2020;14:1035-46. [DOI: 10.1080/17474124.2020.1801413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Ha A, Rui F, Zou B, Yang H, Xue Q, Hu X, Xu Y, Henry L, Barakhat M, Stave CD, Shi J, Wu C, Cheung R, Nguyen MH. Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021. Aliment Pharmacol Ther 2022. [PMID: 35736008 DOI: 10.1111/apt.17096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Alves VPV, Dillman JR, Tkach JA, Bennett PS, Xanthakos SA, Trout AT. Comparison of Quantitative Liver US and MRI in Patients with Liver Disease. Radiology 2022;:212995. [PMID: 35608446 DOI: 10.1148/radiol.212995] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Taheri E, Pourhoseingholi MA, Moslem A, Hassani AH, Mousavi Jarrahi A, Asadzadeh Aghdaei H, Zali MR, Hatami B. The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults. J Diabetes Metab Disord. [DOI: 10.1007/s40200-021-00941-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, Cortez-Pinto H, Crespo J, Cusi K, Dirac MA, Francque S, George J, Hagström H, Huang TT, Ismail MH, Kautz A, Sarin SK, Loomba R, Miller V, Newsome PN, Ninburg M, Ocama P, Ratziu V, Rinella M, Romero D, Romero-Gómez M, Schattenberg JM, Tsochatzis EA, Valenti L, Wong VW, Yilmaz Y, Younossi ZM, Zelber-Sagi S; NAFLD Consensus Consortium. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol 2022;19:60-78. [PMID: 34707258 DOI: 10.1038/s41575-021-00523-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 39.0] [Reference Citation Analysis]
5 Dong B, Chen Y, Lyu G, Qin R. Liver stiffness measurement as a quantitative method for liver fibrosis in children with non-alcoholic fatty liver disease: A meta-analysis. J Paediatr Child Health 2021. [PMID: 34554611 DOI: 10.1111/jpc.15751] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Colucci A, Rocco MC, De Anseris AGE, Nazzaro L, Vajro P, Mandato C. Pediatric vs. adult NAFLD to MAFLD transition: a welcome but tangled path. Exploration of Medicine. [DOI: 10.37349/emed.2021.00051] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Manco M, Panera N, Crudele A, Braghini MR, Bianchi M, Comparcola D, De Vito R, Maggiore G, Alisi A. Angiopoietin-2 levels correlates with disease activity in children with nonalcoholic fatty liver disease. Pediatr Res 2021. [PMID: 34331020 DOI: 10.1038/s41390-021-01666-5] [Reference Citation Analysis]